CA2584456C - Composition avec desmopressine - Google Patents

Composition avec desmopressine Download PDF

Info

Publication number
CA2584456C
CA2584456C CA002584456A CA2584456A CA2584456C CA 2584456 C CA2584456 C CA 2584456C CA 002584456 A CA002584456 A CA 002584456A CA 2584456 A CA2584456 A CA 2584456A CA 2584456 C CA2584456 C CA 2584456C
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
composition according
weight
oxidising agent
desmopressin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002584456A
Other languages
English (en)
Other versions
CA2584456A1 (fr
Inventor
Christina Ulrika Jonius Aston
Lars-Erik Olsson
Lars Anders Ragnar Nilsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring International Center SA
Original Assignee
Ferring International Center SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0600482A external-priority patent/SE0600482L/xx
Application filed by Ferring International Center SA filed Critical Ferring International Center SA
Publication of CA2584456A1 publication Critical patent/CA2584456A1/fr
Application granted granted Critical
Publication of CA2584456C publication Critical patent/CA2584456C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne une nouvelle composition pharmaceutique sous une forme pharmaceutique solide qui comprend de la desmopressine comme ingrédient thérapeutiquement actif. Elle permet d'obtenir une durée de vie améliorée pour ledit ingrédient actif dans ladite forme pharmaceutique.
CA002584456A 2006-03-02 2007-03-01 Composition avec desmopressine Expired - Fee Related CA2584456C (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
SE0600482A SE0600482L (sv) 2006-03-02 2006-03-02 Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
SE0600482-4 2006-03-02
EP06005326.1 2006-03-15
EP06005326A EP1829532B1 (fr) 2006-03-02 2006-03-15 Forme posologique solide stable de la desmopressine
DE202006004746.8 2006-03-24
DE202006004746U DE202006004746U1 (de) 2006-03-02 2006-03-24 Desmopressin umfassende Zusammensetzung
PCT/EP2007/001760 WO2007098945A2 (fr) 2006-03-02 2007-03-01 Composition comprenant de la desmopressine

Publications (2)

Publication Number Publication Date
CA2584456A1 CA2584456A1 (fr) 2007-07-09
CA2584456C true CA2584456C (fr) 2008-07-22

Family

ID=38236353

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002584456A Expired - Fee Related CA2584456C (fr) 2006-03-02 2007-03-01 Composition avec desmopressine

Country Status (2)

Country Link
CA (1) CA2584456C (fr)
WO (1) WO2007098945A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2712622B1 (fr) 2008-05-21 2016-07-13 Ferring B.V. Desmopressine orodispersible pour l'augmentation de la période initiale de sommeil non perturbée par la nycturie
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
CA2484724C (fr) * 2002-05-07 2007-01-16 Ferring B.V. Formulations pharmaceutiques
DK1530967T3 (da) * 2003-11-13 2006-07-03 Ferring Bv Blisterpakning og dertil hörende fast dosisform
PT1550439E (pt) * 2003-12-29 2006-06-30 Ferring Bv Metodo para a preparacao de uma forma solida de dosagem de desmopressina

Also Published As

Publication number Publication date
CA2584456A1 (fr) 2007-07-09
WO2007098945A3 (fr) 2007-11-01
WO2007098945A2 (fr) 2007-09-07

Similar Documents

Publication Publication Date Title
EP1829532B1 (fr) Forme posologique solide stable de la desmopressine
US20080014265A1 (en) Pharmaceutical composition as solid dosage form and method for manufacturing thereof
US20110033535A1 (en) Pharmaceutical composition as solid dosage form and method for manufacturing thereof
ZA200605262B (en) Method for preparing solid dosage form of desmopressin
RU2303439C2 (ru) Фармацевтическая композиция десмопрессина в виде твердой дозированной лекарственной формы и способ ее изготовления
CA2584456C (fr) Composition avec desmopressine
Aston et al. Composition Comprising Desmopressin
AU2004233596B2 (en) Solid dosage form comprising desmopressin
TWI282284B (en) Method for preparing solid dosage form of desmopressin
RU2334505C2 (ru) Способ приготовления твердой лекарственной формы десмопрессина
IL167612A (en) Method for manufacturing a pharmaceutical composition as solid dosage form comprising desmopressin acetate as a therapeutically active agent
CA2511353A1 (fr) Composition pharmaceutique comme forme posologique solide et procede de fabrication associe

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20140303